Navigation Links
EPA Reaches Agreement With American Energy on Clean-Air Violations
Date:4/14/2008

CHICAGO, April 14 /PRNewswire-USNewswire/ -- U.S. Environmental Protection Agency Region 5 has reached an agreement with American Energy Corp. on alleged clean-air violations at the company's coal preparation plant at 43521 Mayhugh Hill Road, Township Highway 88, Beallsville, Ohio.

The agreement, which includes a $40,000 penalty, resolves EPA allegations that AEC failed to comply with testing, notification and reporting requirements at the plant that processes coal from a coal mine.

The company was required to conduct a performance test for opacity, or the amount of light obscured by particulates (dust) from the plant, to determine compliance with the opacity standard.

Inhaling high concentrations of particulates can affect children, the elderly and people with heart and lung diseases the most.

Information about EPA Region 5's air enforcement program is at http://www.epa.gov/region5/air/enforce/index.html. Potential environmental violations may be reported at http://www.epa.gov/compliance/complaints.


'/>"/>
SOURCE U.S. Environmental Protection Agency Region 5
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Spiritual Healer/Psychic-Medium Reaches International Status!
2. EMBL reaches north
3. AK Steel Reaches VEBA Health Care Settlement With Middletown Works Retirees
4. Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival
5. 40 Days for Life Reaches Halfway Point; Planned Parenthood Now in Crisis Mode
6. Blue Cross of California Reaches Out to Members Impacted by Southern California Fires
7. Free Site Offering Patient-Physician Dialog Reaches Milestone
8. Sharp HealthCare Foundation Reaches $50 Million Goal
9. Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary
10. MB Software Corporation Reaches Agreement with Keystone Equity Partners
11. New York City death rate reaches historic low
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 1RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 2RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 3RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 4Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 2Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 3Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 4Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 5Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 6